The Native Antigen Company (NAC) has released a highly purified cytomegalovirus (CMV) native antigen, which has been manufactured in response to the in vitro diagnostics (IVD) industry’s requirement for a cost-effective antigen that can demonstrate a high affinity for IgG and IgM. This latest antigen from NAC’s rapidly increasing portfolio also minimises cross-reactivity and lot-to-lot variation.
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
Barbican Centre, London; and online.
28 April - 1 May
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
28 April, 2026
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 May, 2026
Leonardo Royal Hotel, 245 Broad St, Birmingham, B1 2HQ
5 May, 2026
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
6 May, 2026
